Ophthalmology Journal Anti-VEGF vs Panretinal Photocoagulation Laser Therapy for Diabetic Retinopathy
May 8, 2025
Marie-Michele Macaron, a fourth-year medical student at St. George's University of London and the first author of a pivotal manuscript on diabetic retinopathy, joins esteemed experts to discuss groundbreaking insights. They compare anti-VEGF injections with panretinal photocoagulation laser therapy, revealing significant findings on treatment safety and effectiveness. The conversation highlights the nuances of patient preferences and the importance of comprehensive studies to optimize care in managing diabetic retinopathy, particularly regarding visual acuity and complications.
AI Snips
Chapters
Transcript
Episode notes
Shadowing Sparks Research Interest
- Marie-Michele Macaron was inspired to study diabetic retinopathy treatments while shadowing ophthalmologists as a medical student.
- Conversations with her ophthalmologist father sparked interest in comparing treatment longevity.
Meta-Analysis Captures Real-World Diversity
- Meta-analysis pools data from diverse studies, reflecting real-world variability.
- This approach included PDR patients with or without diabetic macular edema, unlike prior meta-analyses.
Use GRADE to Handle Heterogeneity
- Use the GRADE tool to assess outcome certainty, including study heterogeneity.
- Lower certainty outcomes require cautious interpretation and shared clinical decision-making.